Geisinger will expand its precision medicine project beyond research to preventive care, the Danville, PA-based integrated health system announced Sunday. The project already reports clinically actionable genomic results to research participants and their primary care physicians, and plans to launch a clinical DNA pilot program with 1,000 patients in the next six months. “Understanding the genome warning signals of every patient will be an essential part of wellness planning and health management,” Geisinger President and CEO David Feinberg, M.D., told participants at the HLTH Conference in Las Vegas. “Geisinger patients will be able to work with their family physician to modify their lifestyle and minimize risks that may be revealed.”

Related News Articles

Insights and Analysis
Also in this weekly roundup of health care news: Study says preschoolers are at ‘golden age’ for forming lifelong healthy habits, and the extraordinary effect…
Headline
U.S. News and World Report will host a Twitter chat on building healthy communities at 1:30 p.m. ET Oct. 10.
Insights and Analysis
St. John’s Hospitals in Oxnard, Calif., are ensuring local women get needed preventive cancer care regardless of their income status; Connecticut Children’s…
Headline
Heart attack, stroke and other cardiovascular events were responsible for more than 2.2 million hospital stays and 415,000 deaths involving adults in 2016,…
Insights and Analysis
UMass Memorial is bringing care to low-income children through a mobile clinic; Winona Health is showing children that physical activity can be fun; and…
Insights and Analysis
NCH decided to turn inward and experiment with how it could improve quality of life by focusing on prevention and reducing health care costs.